TRAD CHI MED (00570) Sets 20 March 2026 Board Meeting to Approve FY 2025 Results and Evaluate Final Dividend

Bulletin Express

03/10

China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes deliberation on the declaration of a potential final dividend.

The board currently comprises 12 directors: three executive directors (YANG Jun, LI Hongjian, PENG Li), five non-executive directors (LIU Haijian, LI Xiangrong, ZU Jing, XU Jinghui, HUANG Hao) and four independent non-executive directors (XIE Rong, YU Tze Shan Hailson, QIN Ling, LI Weidong).

The company disclosed the meeting schedule through an announcement filed with the Hong Kong Stock Exchange on 10 March 2026.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1176253694"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176253694\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176253694?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176253694","market":"us","top_or_hot":-1,"title":"TRAD CHI MED (00570) Sets 20 March 2026 Board Meeting to Approve FY 2025 Results and Evaluate Final Dividend","media":"Bulletin Express","content":"<p>China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes deliberation on the declaration of a potential final dividend.</p>\n<p>The board currently comprises 12 directors: three executive directors (YANG Jun, LI Hongjian, PENG Li), five non-executive directors (LIU Haijian, LI Xiangrong, ZU Jing, XU Jinghui, HUANG Hao) and four independent non-executive directors (XIE Rong, YU Tze Shan Hailson, QIN Ling, LI Weidong).</p>\n<p>The company disclosed the meeting schedule through an announcement filed with the Hong Kong Stock Exchange on 10 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TRAD CHI MED (00570) Sets 20 March 2026 Board Meeting to Approve FY 2025 Results and Evaluate Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTRAD CHI MED (00570) Sets 20 March 2026 Board Meeting to Approve FY 2025 Results and Evaluate Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-10 16:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes deliberation on the declaration of a potential final dividend.</p>\n<p>The board currently comprises 12 directors: three executive directors (YANG Jun, LI Hongjian, PENG Li), five non-executive directors (LIU Haijian, LI Xiangrong, ZU Jing, XU Jinghui, HUANG Hao) and four independent non-executive directors (XIE Rong, YU Tze Shan Hailson, QIN Ling, LI Weidong).</p>\n<p>The company disclosed the meeting schedule through an announcement filed with the Hong Kong Stock Exchange on 10 March 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00570","symbol_name":"中国中药","start_time":0,"source_url":"","article_id":"1176253694","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176253694","pubTimestamp":1773132204,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00570":"中国中药"},"translate_title":"TRAD CHI MED(00570)定于2026年3月20日召开董事会批准2025财年业绩并评估末期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00570":1},"content_text":"China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes deliberation on the declaration of a potential final dividend.\nThe board currently comprises 12 directors: three executive directors (YANG Jun, LI Hongjian, PENG Li), five non-executive directors (LIU Haijian, LI Xiangrong, ZU Jing, XU Jinghui, HUANG Hao) and four independent non-executive directors (XIE Rong, YU Tze Shan Hailson, QIN Ling, LI Weidong).\nThe company disclosed the meeting schedule through an announcement filed with the Hong Kong Stock Exchange on 10 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}